These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29886823)

  • 1. Target Molecules and Delivery Vehicles for Anti-HIV Drugs In vitro and In vivo.
    Bolhassani A
    Curr Pharm Des; 2018; 24(29):3393-3401. PubMed ID: 29886823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting strategies for delivery of anti-HIV drugs.
    Ramana LN; Anand AR; Sethuraman S; Krishnan UM
    J Control Release; 2014 Oct; 192():271-83. PubMed ID: 25119469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges.
    Voshavar C
    Curr Top Med Chem; 2019; 19(18):1571-1598. PubMed ID: 31237209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting strategies for Human immunodeficiency virus: a combinatorial approach.
    Saxena SK; Gupta A; Bhagyashree K; Saxena R; Arora N; Banerjee AK; Tripathi AK; Chandrasekar MJ; Gandhi N; Nair MP
    Mini Rev Med Chem; 2012 Mar; 12(3):236-54. PubMed ID: 22356194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
    Khan T; Mayuresh Patkar M; Momin M; Omri A
    Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.
    Gupta S; Kesarla R; Omri A
    Expert Opin Drug Deliv; 2019 Mar; 16(3):287-300. PubMed ID: 30779602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs--modern Trojan horses to combat HIV.
    Ramana LN; Sharma S; Sethuraman S; Ranga U; Krishnan UM
    Eur J Pharm Biopharm; 2015 Jan; 89():300-11. PubMed ID: 25500283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
    Varghese NM; Senthil V; Saxena SK
    J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection.
    Désormeaux A; Bergeron MG
    J Drug Target; 1998; 6(1):1-15. PubMed ID: 9769017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel liquid formulation developed to deliver nanomedicine treatment for HIV/AIDS.
    Nanomedicine (Lond); 2010 Jul; 5(5):684. PubMed ID: 20662639
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of antivirals to skin Langerhans cells--a novel approach to anti-HIV treatment by "antiviral peplotion".
    Becker Y
    Acta Biochim Pol; 1996; 43(1):175-81. PubMed ID: 8790722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting anti-HIV drugs to the CNS.
    Rao KS; Ghorpade A; Labhasetwar V
    Expert Opin Drug Deliv; 2009 Aug; 6(8):771-84. PubMed ID: 19566446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell-Cell HIV Transmission.
    Jiang Y; Cao S; Bright DK; Bever AM; Blakney AK; Suydam IT; Woodrow KA
    Mol Pharm; 2015 Dec; 12(12):4363-74. PubMed ID: 26529558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.
    Gao Y; Kraft JC; Yu D; Ho RJY
    Eur J Pharm Biopharm; 2019 May; 138():75-91. PubMed ID: 29678735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challenge.
    Amiji MM; Vyas TK; Shah LK
    Discov Med; 2006 Aug; 6(34):157-62. PubMed ID: 17234137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of polymeric nanoparticles in AIDS treatment and prevention.
    Khalil NM; Carraro E; Cótica LF; Mainardes RM
    Expert Opin Drug Deliv; 2011 Jan; 8(1):95-112. PubMed ID: 21143001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.